References
- Longcope W. T., Luetscher J. A. Clinical uses of 2,3-dimercaptopropanol (BAL). XI: The treatment of acute mercury poisoning by BAL. J. Clin. Invest. 1946; 25: 557
- Chisolm J. J. Poisoning due to heavy metals. Pediatr. Clin. North Am. 1970; 17: 591
- Zvirblis P., Ellin R. I. Acute systemic toxicity of pure dimercaprol and trimercaptopropanol. Toxicol. Appl. Pharmacol. 1976; 36: 397
- Aposhian H. V. Penicillamine and analogues chelating agents. Ann. N. Y. Acad. Sci. 1971; 179: 481
- Friedreich L., Zimmermann F. Zur Pharmakologie von D-penicillamine. Arzneim-Forsch. (Drug. Res.) 1975; 25: 162
- Aaseth J., Friedheim E. Treatment of methyl mercury poisoining in mice with 2,3-dimercaptosuccinic acid and other complexing thiols. Acta Pharmacol. Toxicol. 1978; 42: 248
- Chenoweth M. B. Clinical use of metal-binding drugs. Clin. Pharmacol. Ther. 1968; 9: 365
- Belonozhko G. A. The treatment of inorganic mercury poisoning with unithiol. Farmakol. Toksikol. (USSR) 1958; 21: 69
- Gabard B. The excretion and distribution of inorganic mercury in the rat as influenced by several chelating agents. Arch. Toxicol. 1976; 35: 15
- Planas-Bohne F., Garard B., Schäffer E. H. Toxicological studies on sodium 2,3-dimercaptopropane-1-sulphonate in the rat. Arzneim. -Forsch. (Drug Res.) 1980; 30: 1291
- Aaseth J. The effect of mercaptodextran on distribution and toxicity of mercury in mice. Acta Pharmacol. Toxicol. 1973; 32: 430
- Jellum E., Aaseth J., Eldjarn L. Mercoptodextran, a metalchelating and disulphide-reducing polythiol of high molecular weight. Biochem. Pharmacol. 1973; 22: 1179
- Friedheim E., Corvi C., Walker C. H. Meso-dimercaptosuccinic acid, a chelating agent for the treatment of mercury and lead poisoning. J. Pharmacol. 1976; 28: 711
- Graziano J. H., Cuccia D., Friedheim E. The pharmacology of 2,3-dimercaptosuccinic acid and its potential uses in arsenic poisoning. J. Pharmacol. Exp. Ther. 1978; 207: 1051
- Magos L. The effects of dimercaptosuccinic acid on the excretion acid distribution of mercury in rats and mice treated with mercuric chloride and methylmercuric chloride. Br. J. Pharmacol. 1976; 56: 479
- Aaseth J., Norseth T. The effect of mercaptodextran and N-acetylhomocysteine on the excretion of mercury in mice after exposure to methyl mercury chloride. Acta Pharmacol. Toxicol. 1974; 35: 23
- Hollander M., Wolfe D. A. Nonparametric Statistical Methods. Wiley, New York 1973
- Peters R. Developments and theoretical significance of British anti-lewisite (BAL). Br. Med. Bull. 1948; 5: 313
- Cikrt M. The influence of unithiol and spironolactone on the biliary excretion of 203Hg in rat. Arch. Toxicol. 1978; 39: 219
- Selye H. Mercury poisoning: Prevention by spironolactone. Science 1970; 169: 775
- Klaassen C. D. Effect of spironolactone on the distribution of mercury. Toxicol. Appl. Pharmacol. 1975; 33: 366
- Takahashi H., Shibuya Y. Preventive mechanism of spironolactone against mercury-induced renal damage: Role of metallothionein. Toxicol. Appl. Pharmacol. 1979; 47: 209
- Jones M. M., Basinger M. A., Weaver A. D., Davis C. M., Vanghn W. K. Comparison of standard chelating agents for acute mercuric chloride poisoning in mice. Res. Commun. Chem. Pathol. Pharmacol. 1980; 27: 363
- Aaseth J., Unpublished Results
- Berlin M., Ullberg S. Increased uptake of mercury in mouse brain caused by 2,3-dimercaptopropanol (BAL). Nature 1963; 197: 84
- Gabard B. Distribution and excretion of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulphonate in the rat. Arch. Toxicol. 1978; 39: 289
- Friedheim E., Graziano J. M., Popovac D., Dragovic D., Kaul B. Treatment of lead poisoning by 2,3-dimercaptosuccinic acid. Lancet 1978; II: 1234